NCT07493421 2026-03-25
To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.
Unidade Local de Saúde São João
Phase NA Recruiting
Clinical Trials
19 trialsNCT07405099 2026-02-27
Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease
National Taiwan University Hospital
Enrolling by invitation
NCT07396662 2026-02-09
Endocrine-exocrine Functions and Prognosis After Pancreatectomy
National Taiwan University Hospital
Recruiting
NCT06478056 2026-02-06
VEINOPAN
University Hospital, Rouen
Phase NA Completed
NCT07382791 2026-02-03
Delayed Gastric Emptying After Pancreatic Surgery
National Taiwan University Hospital
Recruiting
NCT04594772 2025-07-02
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
University of Cincinnati
Phase 2 Active not recruiting
NCT05841706 2025-06-10
Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT02757859 2025-05-20
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
Thomas Jefferson University
Phase NA Recruiting
NCT06980792 2025-05-20
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
Azienda Ospedaliero-Universitaria di Modena
Completed
NCT06944587 2025-04-25
NORPACT-3
Oslo University Hospital
Recruiting
NCT05462496 2024-10-15
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Recruiting
NCT06093009 2023-10-24
The Significance of Postoperative Muscle Wasting in Pancreatic Cancer
National Cheng-Kung University Hospital
Completed
NCT03801915 2023-03-21
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02562716 2022-10-19
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
SWOG Cancer Research Network
Phase 2 Completed
NCT03891472 2019-11-13
Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer
Medical University of Silesia
Phase 2 Completed
NCT02823678 2017-07-28
Pancreas Volume and Diabetes Status Following Pancreatectomy
Florida Hospital Tampa Bay Division
Unknown
NCT02117895 2016-08-11
Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail
Fudan University
Phase 3 Unknown
NCT01412684 2016-08-08
Distal Pancreatectomy With Partial Splenectomy for Pancreatic Tumors
University of Missouri-Columbia
Withdrawn
NCT01492907 2014-08-22
Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer
University of Minnesota
Phase 1 Completed